Applied DNA stock rises 12% on launching monkeypox testing service in New York

Sep. 06, 2022 9:10 AM ETApplied DNA Sciences, Inc. (APDN)By: Ravikash, SA News Editor

Monkeypox title background


  • Applied DNA Sciences (NASDAQ:APDN) said it launched monkeypox testing service to hospital systems and clinical labs in New York State and in states which recognize New York's CLEP/CLIA certification for testing.
  • The launch follows Applied DNA Clinical Labs' (ADCL) receiving full approval from the New York State Department of Health (NYSDOH) for its PCR-based Linea Monkeypox Virus 1.0 Assay as a laboratory developed test (LDT) to detect the Clade II variant of the monkeypox virus, APDN said in a Sept. 6 press release.
  • As of Sept. 2, there were 19,962 total confirmed monkeypox/orthopoxvirus cases in the U.S., as per the U.S. CDC.
  • APDN +12.27% to $3.11 premarket Sept. 6

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.